Northwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for Glioblastoma
Thoughts jondoeuk, as your opinion seemed 180 degrees opposite of what was reported in the JAMA Phase 3 Trial of DCVAx-L for Glioblastoma. Just trying to understand your logic model and thinking on these results.